drugset / Trial / NCT03289429

Antiarrhythmic and Cardioprotective Effects of Atorvastatin Versus Magnesium Sulfate in Cardiac Valve Replacement Surgery

NCT03289429

Phase 4 Unknown 96 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study aims to compare the antiarrhythmic and cardioprotective effects of Atorvastatin versus Magnesium Sulfate after Cardiac valve Replacement Surgery

Timeline

Start
2017-09-24
Primary completion
2018-02
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg
Subject Magnesium Sulfate Other / unclassified 3 g